Cocrystal pharma's novel norovirus antiviral to be presented at department of defense medical conference

Bothell, wash., june 05, 2025 (globe newswire) -- cocrystal pharma, inc. (nasdaq: cocp) announces that its broad-spectrum protease inhibitor cdi-988 will be featured in an oral presentation at the 2025 military health system research symposium (mhsrs) being held august 4-7 in kissimmee, fla.
COCP Ratings Summary
COCP Quant Ranking